Cargando…

Luteolin Inhibits Human Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2-Mediated Angiogenesis

Angiogenesis, the formation of new blood vessels from pre-existing vascular beds, is essential for tumor growth, invasion, and metastasis. Luteolin is a common dietary flavonoid found in fruits and vegetables. We studied the antiangiogenic activity of luteolin using in vitro, ex vivo, and in vivo mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pratheeshkumar, Poyil, Son, Young-Ok, Budhraja, Amit, Wang, Xin, Ding, Songze, Wang, Lei, Hitron, Andrew, Lee, Jeong-Chae, Kim, Donghern, Divya, Sasidharan Padmaja, Chen, Gang, Zhang, Zhuo, Luo, Jia, Shi, Xianglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534088/ https://www.ncbi.nlm.nih.gov/pubmed/23300633 http://dx.doi.org/10.1371/journal.pone.0052279

Ejemplares similares

Quercetin Inhibits Angiogenesis Mediated Human Prostate Tumor Growth by Targeting VEGFR- 2 Regulated AKT/mTOR/P70S6K Signaling Pathways
por: Pratheeshkumar, Poyil, et al.
Publicado: (2012)

Hexavalent chromium induces malignant transformation of human lung bronchial epithelial cells via ROS-dependent activation of miR-21-PDCD4 signaling
por: Pratheeshkumar, Poyil, et al.
Publicado: (2016)

Quercetin inhibits Cr(VI)-induced malignant cell transformation by targeting miR-21-PDCD4 signaling pathway
por: Pratheeshkumar, Poyil, et al.
Publicado: (2016)

Oncogenic transformation of human lung bronchial epithelial cells induced by arsenic involves ROS-dependent activation of STAT3-miR-21-PDCD4 mechanism
por: Pratheeshkumar, Poyil, et al.
Publicado: (2016)

Retraction Note: Oncogenic transformation of human lung bronchial epithelial cells induced by arsenic involves ROS-dependent activation of STAT3-miR-21-PDCD4 mechanism
por: Pratheeshkumar, Poyil, et al.
Publicado: (2019)

FoxM1 and β-catenin predicts aggressiveness in Middle Eastern ovarian cancer and their co-targeting impairs the growth of ovarian cancer cells
por: Pratheeshkumar, Poyil, et al.
Publicado: (2017)

PD-L1 Is an Independent Prognostic Marker in Middle Eastern PTC and Its Expression Is Upregulated by BRAFV600E Mutation
por: Siraj, Abdul K., et al.
Publicado: (2021)

Overexpression of PARP is an independent prognostic marker for poor survival in Middle Eastern breast cancer and its inhibition can be enhanced with embelin co-treatment
por: Siraj, Abdul Khalid, et al.
Publicado: (2018)

Anti-apoptotic proteins and catalase-dependent apoptosis resistance in nickel chloride-transformed human lung epithelial cells
por: YANG, YU-XIU, et al.
Publicado: (2013)

CHD4 Predicts Aggressiveness in PTC Patients and Promotes Cancer Stemness and EMT in PTC Cells
por: Pratheeshkumar, Poyil, et al.
Publicado: (2021)

SUN-132 KLF5 Is a Poor Prognostic Marker and Therapeutic Target for Middle Eastern Papillary Thyroid Carcinoma
por: Al-Kuraya, Khawla S, et al.
Publicado: (2020)

Prognostic Value and Function of KLF5 in Papillary Thyroid Cancer
por: Pratheeshkumar, Poyil, et al.
Publicado: (2021)

Phytochemicals in Cancer Prevention and Therapy
por: Pratheeshkumar, Poyil, et al.
Publicado: (2015)

Krupple-Like Factor 5 is a Potential Therapeutic Target and Prognostic Marker in Epithelial Ovarian Cancer
por: Siraj, Abdul K., et al.
Publicado: (2020)

Purinergic regulation of vascular endothelial growth factor signaling in angiogenesis
por: Rumjahn, S M, et al.
Publicado: (2009)

Mechanoregulation of Vascular Endothelial Growth Factor Receptor 2 in Angiogenesis
por: Miller, Bronte, et al.
Publicado: (2022)

Luteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenografts
por: Cook, Matthew T., et al.
Publicado: (2015)

Fisetin inhibits vascular endothelial growth factor-induced angiogenesis in retinoblastoma cells
por: Wang, Liangjun, et al.
Publicado: (2020)

Acetylbritannilactone Modulates Vascular Endothelial Growth Factor Signaling and Regulates Angiogenesis in Endothelial Cells
por: Zhao, Jingshan, et al.
Publicado: (2016)

Anti-Vascular Endothelial Growth Factor Agents for Ocular Angiogenesis and Vascular Permeability
por: Kubota, Toshiaki, et al.
Publicado: (2012)

Mo polyoxometalate nanoparticles inhibit tumor growth and vascular endothelial growth factor induced angiogenesis
por: Zheng, Wenjing, et al.
Publicado: (2014)

Vascular Endothelial Growth Factor: Much More than an Angiogenesis Factor
por: Senger, Donald R.
Publicado: (2010)

Pivotal role of vascular endothelial growth factor pathway in tumor angiogenesis
por: Lee, Sang Hun, et al.
Publicado: (2015)

Salmonella inhibits tumor angiogenesis by downregulation of vascular endothelial growth factor
por: Tu, Dom-Gene, et al.
Publicado: (2016)

Vascular endothelial growth factor signaling requires glycine to promote angiogenesis
por: Guo, Dongqing, et al.
Publicado: (2017)

The Effect of Stem Cells and Vascular Endothelial Growth Factor on Cancer Angiogenesis
por: Moradi-Gharibvand, Nahid, et al.
Publicado: (2023)

Effects of cellular iron deficiency on the formation of vascular endothelial growth factor and angiogenesis. Iron deficiency and angiogenesis
por: Eckard, Jonathan, et al.
Publicado: (2010)

Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer
por: O'Byrne, K J, et al.
Publicado: (2000)

Vascular Permeability Factor/Vascular Endothelial Growth Factor Induces Lymphangiogenesis as well as Angiogenesis
por: Nagy, Janice A., et al.
Publicado: (2002)

Inhibition of renal cell carcinoma angiogenesis and growth by antisense oligonucleotides targeting vascular endothelial growth factor
por: Shi, W, et al.
Publicado: (2002)

Quercetin inhibits angiogenesis-mediated human retinoblastoma growth by targeting vascular endothelial growth factor receptor
por: Song, Wei, et al.
Publicado: (2017)

Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants.
por: Ziche, M., et al.
Publicado: (1998)

Hypoxia-induced angiogenesis and vascular endothelial growth factor secretion in human melanoma.
por: Rofstad, E. K., et al.
Publicado: (1998)

Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia.
por: Dobbs, S. P., et al.
Publicado: (1997)

ENDOGLIN Is Dispensable for Vasculogenesis, but Required for Vascular Endothelial Growth Factor-Induced Angiogenesis
por: Liu, Zhen, et al.
Publicado: (2014)

Role of Microvessel Density and Vascular Endothelial Growth Factor in Angiogenesis of Hematological Malignancies
por: Chand, Rashika, et al.
Publicado: (2016)

The role of vascular endothelial growth factor in angiogenesis and brain circulation after stroke
por: Cosky, Eric Eugene Paul, et al.
Publicado: (2018)

Expression and association of vascular endothelial growth factor, vascular endothelial growth factor receptor, and phosphorylated signal transducer and activator of transcription factor 3 in malignant gliomas
por: Edura, Praveena, et al.
Publicado: (2023)

Deletion of Endothelial Cell-Specific Liver Kinase B1 Increases Angiogenesis and Tumor Growth via Vascular Endothelial Growth Factor
por: Zhang, Wencheng, et al.
Publicado: (2017)

In Vitro Angiogenesis Inhibition and Endothelial Cell Growth and Morphology
por: Ljoki, Arlinda, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_phree8anobtv59238f4bf8svv4